Login
$LYEL
$14.65 +$0.35 (2.45%) Live

Insider Transactions

What Lyell Immunopharma, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 2 4
Sells 9 29
Total trades 11 41

Shares traded

3 months 12 months
Acquired 4,642,524 5,655,454
Disposed 14,135 256,569
Net activity +4,628,389 +5,398,885

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Lee Gary K. Chief Scientific Officer Nov 10 Sale for tax withholding · S −129 $15.93 −$2.05K 16,091
Hill Stephen J. Chief Operating Officer Nov 10 Sale for tax withholding · S −88 $15.93 −$1.4K 16,728
Bulis Veronica Sanchez VP, Corporate Controller Nov 10 Sale for tax withholding · S −416 $15.93 −$6.63K 14,383
Seely Lynn President and CEO Nov 10 Sale for tax withholding · S −545 $15.93 −$8.68K 63,354
Arch Venture Partners IX, Llc 10% owner Nov 04 Open-market buy · P +2,321,262 $10.77 +$25M 3,747,790
Arch Venture Fund XIII, L.p. 10% owner Nov 04 Open-market buy · P +2,321,262 $10.77 +$25M 3,747,790
Aguirre Jarrad Mattieu Chief Medical Officer Oct 12 Sale for tax withholding · S −422 $8.63 −$3.64K 19,857
Shook David Chief Medical Officer Sep 10 Sale for tax withholding · S −500 $12.70 −$6.35K 20,423
Seely Lynn President and CEO Aug 21 Sale for tax withholding · S −9,589 $15.54 −$149K 63,899
Hill Stephen J. Chief Operating Officer Aug 21 Sale for tax withholding · S −989 $15.54 −$15.4K 16,816
Lee Gary K. Chief Scientific Officer Aug 21 Sale for tax withholding · S −1,457 $15.54 −$22.6K 16,220
Lee Gary K. Chief Scientific Officer Aug 10 Sale for tax withholding · S −131 $14.34 −$1.88K 17,677
Seely Lynn President and CEO Aug 10 Sale for tax withholding · S −390 $14.34 −$5.59K 73,488
Bulis Veronica Sanchez VP, Corporate Controller Aug 10 Sale for tax withholding · S −621 $14.34 −$8.91K 14,799
Hill Stephen J. Chief Operating Officer Aug 10 Sale for tax withholding · S −89 $14.34 −$1.28K 17,805
Innovative Cellular Therapeutics Holdings Ltd 10% owner Jul 27 Other Transaction · J −38,500 — — 2,818,980
Innovative Cellular Therapeutics Holdings Ltd 10% owner Jul 27 Other Transaction · J −44,000 — — 2,774,980
Innovative Cellular Therapeutics Holdings Ltd 10% owner Jul 17 Open-market sale · S −10 $13.70 −$137 2,857,480
Innovative Cellular Therapeutics Holdings Ltd 10% owner Jul 16 Open-market sale · S −10 $13.73 −$137 2,857,490
Innovative Cellular Therapeutics Holdings Ltd 10% owner Jun 29 Other Transaction · J −76,000 — — 2,857,500

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support